FendX Technologies Inc.

FendX Technologies Inc. is pleased to announce that its Japanese patent application was granted further supporting the Company’s commitment to build on its intellectual property position and coverage for the Company’s nanotechnology, its methods and products in development. NEWS RELEASE: https://lnkd.in/gRSt3fdw CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #REPELWRAP #Nanotechnology

Dr. Carolyn Myers, CEO of Fendx Technologies Inc, presented and met investors at the Global Markets Forum in NYC on October 9, 2024, sponsored by Aquis Stock Exchange, the Canadian Securities Exchange and the OTC Markets. FendX was also a part of the Small Cap Growth Virtual Investor Conference, also hosted by the OTC Markets: https://lnkd.in/gpFaGRyE

FendX Technologes Inc. announces successful completion of the pilot manufacturing phase and is now advancing to evaluate the repelling effectiveness of REPELWRAP™ film in real-world settings. NEWS RELEASE: https://lnkd.in/gPngGTPY CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #REPELWRAP #Nanotechnology

Hi everyone - I am looking for a new senior level commercial role in pharmaceuticals/biotech/medical devices/healthcare. Thank you in advance for any connections, advice, or opportunities you can offer. #OpenToWork

FendX Technologies Inc. is pleased to announce the publication of results from research conducted at McMaster University demonstrating that its AI-enhanced nanotechnology detects bacterial contamination at 96.7% accuracy on surfaces. NEWS RELEASE: https://lnkd.in/ggrmvuVa CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #AIEnhanced #Nanotechnology

FendX Technologies Inc. is pleased to have Dr. Rohit Ramchandani provide his extensive public health expertise to further FendX’s goal of advancing their innovative solutions for pathogen control and safety. NEWS RELEASE: https://lnkd.in/gWwjtSPv CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #PublicHealthExpert #InfectiousDiseaseControl

FendX Technologies Inc., a nanotechnology company developing surface protection coatings, highlights a new report from the CDC highlighting the increased incidence of infections caused by six superbugs and emphasized the need to invest in the prevention-focused public health initiatives that can effectively control their spread. NEWS RELEASE: https://lnkd.in/gyYzqb95 CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #CDCReport #Superbugs DISCLAIMER: https://lnkd.in/g3jg8C2N

FendX Technologies Inc., a nanotechnology company developing surface protection coatings, is pleased to announce that it continues to progress towards finalizing the film manufacturing process with Dunmore International Corp. NEWS RELEASE: https://lnkd.in/g6sYWbrv CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #Development #Dunmore DISCLAIMER: https://lnkd.in/g3jg8C2N

FendX Technologies Inc. plans to test their REPELWRAP™ film, designed to repel pathogens on high touch surfaces, at LA Fitness at the Vaughan, Ontario location. NEWS RELEASE: https://lnkd.in/gVB3DC5M CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #LAFitness #Dunmore DISCLAIMER: https://lnkd.in/g3jg8C2N

FendX Technologies provides corporate update from CEO and President Dr. Carolyn Myers. News release: https://lnkd.in/gTm22Ueu CSE: FNDX | OTCQB: FDXTF | FSE: E8D #FendX #CorporateUpdate #ShareholderLetter Disclaimer: https://loom.ly/_8H7p_M